The role of anti-CENP-B and anti-SS-B antibodies in breast cancer

Neoplasma

Volumn 52, Issue 1, 2005, Pages 32-35

  Atalay, C ^a   Atalay, G ^b   Yilmaz, K B ^a   Altinok, M ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b Med Lab Laboratories   (Turkey)

Author keywords

Anti CENP B; Anti SS B; Autoimmunity; Breast cancer

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; DNA ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LA ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN P53; RO ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BREAST CANCER; BREAST DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEROLOGY; TUMOR VOLUME;

EID: 14744276160     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ABU-SHAKRA M, BUSKILA D, EHRENFELD M, CONRAD K, SHOENFELD Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001; 60: 433-440.
2. ABU-SHAKRA M, GUILLEMIN F, LEE P. Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 460-464.
3. ANSAR AHMED S, AUFDEMORTE TB, CHEN JR, MONROYA AI, OLIVE D, TALAL N. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmun 1989; 2: 543-552.
4. CASIANO CA, HUMBEL RL, PEEBLES C, COVINI G, TAN EM. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. J Autoimmun 1995; 8: 575-586.
5. CLARK GM, ALLRED DC, HILSENBECK SG, CHAMNESS GC, OSBORNE CK et al. Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer. Cancer Res 1997; 57: 5505-5508.
6. COVINI G, VON MÜHLEN CA, PACCHETTI S, COLOMBO M, CHAN EKL, TAN EM. Diversity of antinuclear antibody responses in hepatocellular carcinoma. J Hepatology 1997; 26: 1255-1265.
7. EARNSHAW WC, ROTHFIELD N. Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma 1985; 91: 313-321.
8. FURUKAWA F, LYONS MB, LEE LA, COULTER SN, NORRIS DA. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 1988; 141: 1480-1488.
9. GUARDIA C, CASIANO CA, TRINIDAD-PINEDO J, BAEZ A. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 2001; 23: 104-112.
10. IMAI H, OCHS RL, KIYOSAWA K, FURUTA S, NAKAMURA RM, TAN EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992; 140: 859-870.
11. LIAO H, WINKFEIN RJ, MACK G, RATTNER JB, YEN TJ. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 1995; 130: 507-518.
12. NASCHITZ JE, YESHURUN D, ROSNER I. Rheumatic manifestations of occult cancer. Cancer 1995; 75: 2954-2958.
13. RATTNER JB, REES J, WHITEHEAD CM, CASIANO CA, TAN EM et al. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 1997; 20: 308-319.
14. SYRIGOS KN, CHARALAMBOPOULOS A, PLIARCHOPOULOU K, VARSAMIDAKIS N, MACHAIRAS A, MANDREKAS D. The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer Res 2000; 20: 4351-4354.
15. TOMONAGA T, MATSUSHITA K, YAMAGUCHI S, OOHASHI T, SHIMADA H et al. Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res 2003; 63: 3511-3516.
16. VIG BK, LATOUR D, BROWN M. Localization of anti-CENP antibodies and alphoid sequences in acentric heterochromatin in a breast cancer cell line. Cancer Genet Cytogenet 1996; 88: 118-125.
17. WANG D, CHAN EKL. 17-β-estradiol increases expression of 52-kDa and 60-kDa SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7. J Invest Dermatol 1996; 107: 610-614.
18. WASSERMAN J, GLAS u, BIOMGREN H. Autoantibodies in patients with carcinoma of the breast: correlation with prognosis. Clin Exp Immunol 1975; 19: 417-422.
19. ZHANG JY, ZHU W, IMAI H, KIYOSAWA K, CHAN EKL, TAN EM. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clin Exp Immunol 2001; 125: 3-9.